100 followers
RT @FrontImmunol: New Research: Sintilimab-Induced Autoimmune Diabetes in a Patient With the Anti-tumor Effect of Partial Regression: Conte…
RT @FrontImmunol: New Research: Sintilimab-Induced Autoimmune Diabetes in a Patient With the Anti-tumor Effect of Partial Regression: Conte…
New Research: Sintilimab-Induced Autoimmune Diabetes in a Patient With the Anti-tumor Effect of Partial Regression: Context Immune checkpoint blockades (ICBs) have been approved widely to treat various malignancies. Autoimmune diabetes… https://t.co/TWqYxr
Sintilimab-Induced Autoimmune Diabetes in a Patient With the Anti-tumor Effect of Partial Regression. #lymphoma #lymsm https://t.co/HkEqUmsP28